why choose us

First received: August 11, 2022

Clinical Trial: Circadian as A Prognostic Factor For Radiation Response in Cervical Cancer

Study Status: Completed

Recruit Status: Completed

Condition: Cervical Cancer
Radiotherapy Side Effect

Study Type: Interventional


Official Title: Influence of Radiation Patterns Following Circadian Rhythm Upon Response of Radiotherapy of Uterine Cervical Cancer : Melatonin as a Radiosensitivity and Biological Marker

Brief Summary: The study was a Randomized Clinical Trial (RCT) or clinical trial comparing the results of radiation treatment of 2 treatment groups, i.e. subject groups irradiated in the morning and in the afternoon, to check melatonin levels in cervical cancer patients. Since it is known that the function of melatonin is as an antiproliferation substance or hormone, induces apoptosis, inhibits invasion and metastasis.

Read more